News, Results and Updates from the I-SPY 2 Study and
the field of Breast Cancer research.

Quintiles Provides $2.6M Grant for I-SPY 2 TRIAL

14 Apr 2011 | No Comments | posted by admin | in Health, News

Quintiles announced today that it will contribute a total of $2.6 million over four years to support I-SPY 2, a unique adaptive clinical trial designed to develop breast cancer therapies twice as quickly and at one-fifth the cost of current methods.

The design of the I-SPY 2 trial represents a major advance in breast cancer research with promising implications for other cancers and other diseases. Quintiles will make its grant in support of I-SPY 2 through QuantumLeap Healthcare Collaborative, a 501(c)(3) non-profit foundation and a co-project manager of the trial.

• Click Here to read The full Press Release